"A new study led by Trinity College Dublin, in Ireland, finds that controlling or raising levels of the immune system
component IL-18 in the retinas of patients with dry age-related
macular degeneration (AMD), could prevent it progressing into
the wet form of the disease," so goes the
Medical News Today post. "The researchers write about their findings in the 8 April online issue of
Nature
Medicine."
Read more.
No comments:
Post a Comment